Genetic Analysis AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
17
About the Report
About the Report
Summary
Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that mapping of microbiota by utilizing the GA-map technology to develop IVD tests in various diseases. The company develops gene-based routine tests for the mapping and diagnosis of diseases related to dysbiosis and bacterial imbalances in the digestive system of irritable bowel syndrome and IBD patients. It services include gut microbiota, patient testing and clinical research services. Genetic Analysis provides gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients. The company's technology utilizes common and variable DNA sequences within specified 16S rRNA gene of the bacteria to identify the different bacteria. Its GA-map ProbeTool software program uses search mechanisms to find combinations of DNA probes that can be used in the test. The company's GA-map technology supports to generate profiles of a person's microbiota and correlate such profiles to different health conditions. Genetic Analysis is headquartered in Oslo, Norway.
Genetic Analysis AS-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Genetic Analysis AS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Genetic Analysis Raises USD 2 Million In Venture Financing 11
Partnerships 12
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Licensing Agreements 13
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS-Key Competitors 14
Genetic Analysis AS-Key Employees 15
Genetic Analysis AS-Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17
List of Figure
List of Figures
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Genetic Analysis AS, Pharmaceuticals & Healthcare, Key Facts 2
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genetic Analysis AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genetic Analysis AS, Deals By Therapy Area, 2012 to YTD 2018 8
Genetic Analysis AS, Medical Devices Deals, 2012 to YTD 2018 9
Genetic Analysis AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genetic Analysis Raises USD 2 Million In Venture Financing 11
Genetic Analysis Enters into Agreement with Bio-Rad Labs 12
Applied BioCode Enters Into Licensing Agreement With Genetic Analysis 13
Genetic Analysis AS, Key Competitors 14
Genetic Analysis AS, Key Employees 15
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.